Candel Therapeutics (CADL)
Nasdaq • CADL • US1374041093
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 29, 2026, ORTEX estimated 21.7% of free float sold short, 13.6 days to cover, cost to borrow 0.73%. Sign up for live short interest data.
Market Cap
644m USD | # 5639 in US
Volume
1.26m shares | 13.2m USD
Shares Outstanding
76.52m
Free Float Shares
78.70% | 60.22m
